Discover the National Fibromyalgia Association's mission to enhance life for people with fibromyalgia through awareness, education, support, and advocacy efforts.

Weight gain or obesity is a common concern in India. While lifestyle factors, hormonal imbalances, or medications are often ...

As memories of the Covid pandemic fade, many patients continue to wrestle with its aftermath. There are still many unknowns about long Covid, but new research has identified eight different ways ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

Nov. 6, 2025 -- Fibromyalgia affects about 4 million U.S. adults. Though its cause remains unclear, it can be effectively diagnosed, treated, and managed. But what exactly is fibromyalgia, and why is ...

There’s a lot to focus on when it comes to treating fibromyalgia. Learn whether you could benefit from having more mental health support, better medication options, help identifying triggers, or ...

If you or a loved one has fibromyalgia, you may be considering treatment options. One medication you might hear about is Savella (milnacipran). Fibromyalgia is a long-lasting condition that most ...

TNX-102 SL is the first new fibromyalgia treatment approved in over 15 years, joining three other treatments. Phase 3 trials showed significant pain reduction and good tolerance, with improvements in ...

Following decades of limited treatment options, people living with fibromyalgia will soon have access to a novel therapy designed to tackle the condition’s most elusive symptom: Poor-quality sleep.

Tonix Pharmaceuticals was founded in 2010 to develop and bring to market a drug for fibromyalgia. Fifteen years later, the New Jersey company has accomplished its mission with the FDA's endorsement of ...

Please provide your email address to receive an email when new articles are posted on . The approval is supported by data from multiple phase 3 clinical trials evaluating Tonmya’s safety and efficacy.

First recognized by the American Medical Association (AMA) in 1987 as a defined disease and cause of illness and disability, ...